Status:
RECRUITING
Study on the Long-Term Risk of Recurrence of Anoperineal Fistula in Crohn's Disease
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Crohn Disease
Eligibility:
All Genders
18+ years
Brief Summary
This research aims to evaluate the long-term recurrence risk of perianal fistulas in Crohn's disease patients who have undergone treatment with anti-TNF therapy and seton drainage.The research seeks t...
Detailed Description
Scientific Justification : ● Perianal fistulas are a common and challenging complication of Crohn's disease, significantly impacting patient quality of life. Infliximab, an TNFα antagonist has shown ...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of Crohn's disease
- drainage of an anal fistula with seton combined with the initiation of anti-TNF alpha treatment
- Patient who was treated in the digestive center of the Toulouse University Hospital for drainage of an anal fistula between January 1, 2000 and December 31, 2010
Exclusion
- Patient followed less than 6 months after seton drainage
Key Trial Info
Start Date :
September 17 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2027
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT06514092
Start Date
September 17 2024
End Date
August 1 2027
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Toulouse
Toulouse, France